Arrowhead Pharmaceuticals Inc.


Market Cap$3.29B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Arrowhead Pharmaceuticals Inc.Arrowhead Pharmaceuticals Inc.-70%-97%--

Target Price by Analysts

70.2% upsideArrowhead Pharmaceuticals Target Price DetailsTarget Price

Current Fair Value

192.1% downside

Overvalued by 192.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.29 Billion
Enterprise Value$2.77 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-4.25
Outstanding Shares124,200,230
Avg 30 Day Volume987,787


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-6.99
Price to Sales-
Price to Book Ratio7.93
Enterprise Value to Revenue78.04
Enterprise Value to EBIT-5.84
Enterprise Value to Net Income-6
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Arrowhead Pharmaceuticals Inc.

CEO: Christopher Anzalone